These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10875318)

  • 1. Weak androgen levels, glucocorticoid therapy, and bone mineral density in postmenopausal women with rheumatoid arthritis.
    Fiter J; Nolla JM; Navarro MA; Gómez-Vaquero C; Rosel P; Mateo L; Roig-Escofet D
    Joint Bone Spine; 2000; 67(3):199-203. PubMed ID: 10875318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis?
    Sahin G; Guler H; Incel N; Sezgin M; As I
    Int J Fertil Womens Med; 2006; 51(2):70-4. PubMed ID: 16881382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of circulating androgens on bone mineral density in postmenopausal women.
    Tok EC; Ertunc D; Oz U; Camdeviren H; Ozdemir G; Dilek S
    Maturitas; 2004 Jul; 48(3):235-42. PubMed ID: 15207889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.
    Hall GM; Perry LA; Spector TD
    Ann Rheum Dis; 1993 Mar; 52(3):211-4. PubMed ID: 8484674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: A preliminary report.
    Sahin G; Guler H; Sezgin M; Incel NA; Polat G
    Rheumatol Int; 2006 Jul; 26(9):805-9. PubMed ID: 16362366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
    Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
    Silva RG; Pippa MG; Zerbin CA
    Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
    Hämäläinen H; Kaarela K; Kröger H; Kauppi M; Järvenpää S; Hakala M; Kotaniemi A
    Joint Bone Spine; 2007 Oct; 74(5):482-7. PubMed ID: 17905634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormone status and bone mineral density in men with rheumatoid arthritis.
    Mateo L; Nolla JM; Bonnin MR; Navarro MA; Roig-Escofet D
    J Rheumatol; 1995 Aug; 22(8):1455-60. PubMed ID: 7473465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis.
    Sambrook PN; Eisman JA; Champion GD; Pocock NA
    Arthritis Rheum; 1988 Aug; 31(8):973-8. PubMed ID: 2970263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis.
    Fassio A; Idolazzi L; Jaber MA; Dartizio C; Viapiana O; Rossini M; Gatti D
    Reumatismo; 2016 Sep; 68(2):65-71. PubMed ID: 27608794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus.
    Formiga F; Moga I; Nolla JM; Navarro MA; Bonnin R; Roig-Escofet D
    Clin Exp Rheumatol; 1997; 15(4):387-92. PubMed ID: 9272299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
    Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
    J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
    Wang Y; Zhao R; Gu Z; Dong C; Guo G; Li L
    Osteoporos Int; 2020 Aug; 31(8):1401-1409. PubMed ID: 32291467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis.
    Meinen R; Galli-Lysak I; Villiger PM; Aeberli D
    BMC Musculoskelet Disord; 2016 Aug; 17():324. PubMed ID: 27491286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.